Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

FDA Announces Discontinuation Of Manufacture Of DYMISTA Nasal Spray, 137 mcg; 50 mcg A Registered Trademark Of Meda Pharmaceuticals Inc., A Viatris Company

Author: Benzinga Newsdesk | September 04, 2025 10:37am

https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/202236s021lbl.pdf

Posted In: VTRS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist